Evotec (EVO)

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

O preço da ação Evotec SE American Depositary Shares (EVO) hoje é de , refletindo uma movimentação de NaN% desde que o mercado abriu. A capitalização de mercado da empresa é de $ 1,17 bi, com um volume comercial diário de  ações. O preço de fechamento anterior foi .

Vamos começar? Siga os passos abaixo ou leia nosso guia sobre como comprar Evotec ações na Kraken a partir de US$ 10.